Marc Derive
5Patents
2h-index
11Co-inventors
44Inventor score
Filing activity: Apr 8, 2011 → Jul 9, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9657081B2 | Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases | Human Necessities | 3 | Active |
| US9815883B2 | Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof | Human Necessities | 2 | Active |
| US9255136B2 | Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof | Human Necessities | 2 | Active |
| US10948498B2 | Methods and kits for predicting the risk of having a cardiovascular disease or event | Physics | 1 | Active |
| US12364733B1 | Method for treating septic shock | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.